Skip to content

Clinical trials

Phase 2 trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2 Country / region: Hong Kong Clear all

462 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20035
200410
200512
200613
200715
200814
200917
201020
201121
201216
201314
201420
201516
201620
201717
201826
201919
202038
202135
202222
202324
202425
202521
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed265
Terminated55
Recruiting54
Active, not recruiting40
Unknown status34
Not yet recruiting7
Withdrawn6
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong64
The University of Hong Kong52
Novartis Pharmaceuticals32
Hoffmann-La Roche24
Pfizer22
GlaxoSmithKline20
Gilead Sciences15
AstraZeneca11
Bayer11
Bristol-Myers Squibb11

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung40
Carcinoma, Hepatocellular32
Hepatitis B, Chronic27
Hepatitis B21
Breast Neoplasms19
Neoplasms17
Lung Neoplasms16
Diabetes Mellitus, Type 213
Non-alcoholic Fatty Liver Disease13
Liver Neoplasms12

Trials

Showing 1 to 25 of 462. Each trial links to its page on Pharma Observatory.

362 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.